Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.490
+0.290 (13.18%)
Nov 2, 2026, 1:06 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 67.12 million as of November 2, 2026. It is the 43,719th most valuable company in the world and the 262nd biggest in Norway. Its market cap has decreased by 27.36% in one year.
Market Cap
67.12M
Enterprise Value
147.34M
Revenue
48.96M
Global Rank
Country Rank
#262 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 67.12M, a decrease of -89.96%. That is a compound annual growth rate of -33.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 67.12M | -24.09% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.97B |
| Thor Medical ASA | 1.70B |
| ArcticZymes Technologies ASA | 1.10B |
| Nykode Therapeutics AS | 981.27M |
| Lytix Biopharma ASA | 607.51M |
| Zelluna ASA | 513.60M |
| Oncoinvent ASA | 422.86M |
| SoftOx Solutions AS | 292.63M |